Jeff Yass’s Aardvark Therapeutics AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$321K Buy
60,976
+36,951
+154% +$225K ﹤0.01% 10808
2026
Q2
$138K Buy
+24,025
New +$112K ﹤0.01% 12267

Other funds holding AARD

Jeff Yass's AARD Position: Q3 2026 in Review

Jeff Yass increased its Aardvark Therapeutics (AARD) stake by 154% in Q3 2026, buying an estimated $225K and bringing the position to 60,976 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #10808.

Jeff Yass first reported a position in AARD in Q2 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

  • Jeff Yass held 60,976 shares of Aardvark Therapeutics worth $321K as of Q3 2026.
  • Jeff Yass bought 36,951 Aardvark Therapeutics shares in Q3 2026, an estimated $225K.
  • Aardvark Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10808 holding.
  • Jeff Yass first reported a position in Aardvark Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.